KONVOMEP

Serial Number 90231566
Registration 7115811
700

Registration Progress

Application Filed
Oct 2, 2020
Under Examination
Jun 8, 2021
Approved for Publication
Apr 13, 2021
Published for Opposition
Apr 13, 2021
Registered
Jul 18, 2023

Trademark Image

KONVOMEP

Basic Information

Serial Number
90231566
Registration Number
7115811
Filing Date
October 2, 2020
Registration Date
July 18, 2023
Published for Opposition
April 13, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jul 18, 2023
Registration
Registered
Classes
005

Rights Holder

Azurity Pharmaceuticals, Inc.

03
Address
8 Cabot Road, Suite 2000
Woburn, MA 01801

Ownership History

Azurity Pharmaceuticals, Inc.

Original Applicant
03
Woburn, MA

Azurity Pharmaceuticals, Inc.

Owner at Publication
03
Woburn, MA

Azurity Pharmaceuticals, Inc.

Original Registrant
03
Woburn, MA

Legal Representation

Attorney
Douglas R. Wolf

USPTO Deadlines

Next Deadline
1304 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230718)
Due Date
July 18, 2029
Grace Period Ends
January 18, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
Mar 19, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Jul 18, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jul 18, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 13, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Jun 12, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
May 30, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 5, 2023 IUAF S USE AMENDMENT FILED Loading...
May 30, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 5, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 13, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 11, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 11, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 11, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 13, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 11, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 11, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 11, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 24, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 22, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 22, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 22, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 8, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 13, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 13, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 9, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 4, 2021 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 4, 2021 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 4, 2021 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Mar 4, 2021 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Mar 1, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 18, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 005
proton pump inhibitors; pharmaceutical products for the treatment of gastrointestinal disorders, gastric and duodenal ulcers, erosive esophagitis, and gastroesophageal reflex disease, or GERD
First Use Anywhere: Apr 5, 2023
First Use in Commerce: Apr 5, 2023

Classification

International Classes
005